Literature DB >> 25126308

Hypertension management: an update.

Quang Nguyen1, Joann Dominguez2, Loida Nguyen3, Nageshwara Gullapalli4.   

Abstract

Hypertension is a significant and costly public health problem. It is a major, but modifiable contributor for the development of cardiovascular disease. Randomized controlled trials have shown that controlling hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. The risk of developing these hypertension-related complications is continuous, starting at a blood pressure level as low as 115/75 mm Hg. Despite the inherent health risks associated with uncontrolled hypertension, elevated blood pressure remains inadequately treated in the majority of patients. This article reviews guidelines for optimal evaluation of hypertension and current therapeutic options available to combat this common yet pervasive disease.

Entities:  

Year:  2010        PMID: 25126308      PMCID: PMC4106550     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  33 in total

Review 1.  'Hypertension' and 'microalbuminuria': the bell tolls for thee.

Authors:  J P Forman; B M Brenner
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

2.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

3.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

4.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

5.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

6.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

7.  Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.

Authors:  Yagiz Uresin; Addison A Taylor; Charles Kilo; Diethelm Tschöpe; Massimo Santonastaso; Ghionul Ibram; Hui Fang; Andrew Satlin
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2007-12       Impact factor: 1.636

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Aliskiren combined with losartan in type 2 diabetes and nephropathy.

Authors:  Hans-Henrik Parving; Frederik Persson; Julia B Lewis; Edmund J Lewis; Norman K Hollenberg
Journal:  N Engl J Med       Date:  2008-06-05       Impact factor: 91.245

10.  All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.

Authors:  Michael E Ernst; Barry L Carter; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-01       Impact factor: 3.738

View more
  24 in total

Review 1.  Anesthetic Management of the Hypertensive Patient: Part I.

Authors:  Russell Yancey
Journal:  Anesth Prog       Date:  2018

2.  Blood Viscosity, Glycemic Markers and Blood Pressure: A Study in Middle-Aged Normotensive and Hypertensive Type 2 Diabetics.

Authors:  Yogita Dhas; Joyita Banerjee; Neetu Mishra
Journal:  Indian J Clin Biochem       Date:  2018-11-01

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

4.  Association of sleep trajectory in adulthood with risk of hypertension and its related risk factors: the China Health and Nutrition Survey.

Authors:  Yuexuan Wang; Wanying Hou; Sultan Mehmood Siddiqi; Changhao Sun; Tianshu Han; Jianjun Yang
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

5.  Effect of Methanol Extract of Baobab (Adansonia digitata L.) Fruit Pulp on NG-Nitro-L-Arginine Methyl Ester (L-NAME) Induced Hypertension in Rats.

Authors:  Abubakar Alhaji Liman; Aliyu Salihu; Elewechi Onyike
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-04-07

6.  Long-term follow-up of patients undergoing renal sympathetic denervation.

Authors:  Victor J M Zeijen; Lida Feyz; Rajiv Nannan Panday; Kevin Veen; Jorie Versmissen; Isabella Kardys; Nicolas M Van Mieghem; Joost Daemen
Journal:  Clin Res Cardiol       Date:  2022-07-18       Impact factor: 6.138

7.  The effect of calcium and vitamin D supplements on blood pressure in postmenopausal women: myth or reality?

Authors:  Farnaz Sharifi; Reza Heydarzadeh; Reza Golchin Vafa; Mohammadhossein Rahmani; Mohammadjavad Mehdizadeh Parizi; Amin Ahmadi; Bardia Zamiri; Mohammad Montaseri; Javad Kojuri
Journal:  Hypertens Res       Date:  2022-05-13       Impact factor: 5.528

8.  Ensemble-AHTPpred: A Robust Ensemble Machine Learning Model Integrated With a New Composite Feature for Identifying Antihypertensive Peptides.

Authors:  Supatcha Lertampaiporn; Apiradee Hongsthong; Warin Wattanapornprom; Chinae Thammarongtham
Journal:  Front Genet       Date:  2022-04-28       Impact factor: 4.772

9.  Simultaneous Determination of Hydrochlorothiazide and Irbesartan from Pharmaceutical Dosage Forms with RP-HPLC.

Authors:  Sevinç KurbanoĞlu; Aysu Yarman
Journal:  Turk J Pharm Sci       Date:  2020-10-30

10.  Adding a New Medication Versus Maximizing Dose to Intensify Hypertension Treatment in Older Adults : A Retrospective Observational Study.

Authors:  Carole E Aubert; Jeremy B Sussman; Timothy P Hofer; William C Cushman; Jin-Kyung Ha; Lillian Min
Journal:  Ann Intern Med       Date:  2021-10-05       Impact factor: 51.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.